The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

XLI.e

ARDS - Acute lung injury

Publications

Arora R, Kisiel M, MacColl C

Panitumumab-induced pulmonary toxicity.

Current oncology (Toronto, Ont.) 2019 Oct;26;e700-e702 — 2019 Oct — e700-e702

Al-Asadi O, Almusarhed M, Rizvi SAJ, Saka W

Fatal interstitial lung disease caused by Panitumumab-containing chemotherapy regimen.

Ecancermedicalscience 2018;12;841 — 2018 — 841